Introduction

You are being invited to participate in a research study to investigate the knowledge, attitudes and current practices of pharmacovigilance, among Medical Doctors & Pharmacists in South Africa.  The study is conducted by Ms Nyeleti Rikhotso, in fulfillment of the Master of Science Degree at the University of Stellenbosch, Division of Clinical Pharmacology. You were selected as a possible participant in this study because you are a Medical Doctor or Pharmacist in South Africa.

The aim of this study is to investigate the factors influencing the low adverse drug reaction (ADR) reporting levels in South Africa. The WHO requirement is for submission of Individual Case Safety Reports (ICSRs) to the Vigibase database. The investigation will be conducted by assessing the knowledge, attitudes and current practices of pharmacovigilance, among Medical Doctors & Pharmacists in South Africa.

How big is this study?
384 Medical Doctors & Pharmacists combined are required for the conduct of this study.

What are the benefits of participating in the study?
The information gathered through this study will contribute towards science in general and more so towards the endeavor to promote post marketing drug surveillance. You will not be reimbursed to participate in this study and you will not bear any costs for participating.

Question Title

* 1. What type of health institution do you work in? (i.e. private practice, public/private hospital, hospital pharmacy, retail pharmacy, etc.)

Question Title

* 3. Age (Years)

0 100
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 4. Average patients seen per day

Question Title

* 5. Professional level

Question Title

* 6. At which University did you achieve your undergraduate Medical/Pharmacy degree?

Question Title

* 7. Select a definition of Pharmacovigilance below by ticking the box next to the correct alphabet letter:

Question Title

* 8. The most important purpose of pharmacovigilance is:

Question Title

* 10. Where is the Pharmacovigilance unit situated in South Africa?

Question Title

* 11. What does NADEMC stand for?

Question Title

* 12. What is the name of the International Centre for ADR monitoring?

Question Title

* 13. Tick all the applicable minimum information required when reporting an ADR. More than one option may apply.

Question Title

* 14. Tick appropriate option for each question below

  Yes No Unfamiliar
Do you think reporting of adverse drug reactions is necessary?
Do you have any concern about the risk(s) associated with medicines you prescribe?
Do you think you have time to report suspected ADR’s?
Do you think it may be difficult to decide whether an adverse drug reaction has occurred?
Do you think there’s adequate awareness regarding pharmacovigilance in your professional environment?

Question Title

* 18. If your answer to the above question was “no”, select the most appropriate reason(s) below; more than one may apply:

Question Title

* 20. Tick next to all the methods below that you believe may improve ADR reporting in South Africa. More than one may apply

0 of 20 answered
 

T